Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myelomonocytic, Chronic

Explore clinical trials studying Leukemia, Myelomonocytic, Chronic. Study availability and eligibility vary by location and protocol.

20 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myelomonocytic, Chronic trial results

Recruiting

Pacritinib vs. Hydroxyurea in Advanced Proliferative Chronic Myelomonocytic Leukemia

NCT07033598

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +10 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Winship Cancer Institute at Emory Atlanta, Georgia, United States
  • Mayo Clinic Rochester Rochester, Minnesota, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Active, not recruiting

Roll-over Study for Patients Who Have Completed a Prior Novartis-sponsored Sabatolimab (MBG453) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Sabatolimab.

NCT05201066

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations
  • Oregon Health Sciences University Portland, Oregon, United States
  • Huntsman Cancer Institute Univ of Utah Salt Lake City, Utah, United States
  • Novartis Investigative Site Clayton, Victoria, Australia
  • Novartis Investigative Site Florianópolis, Santa Catarina, Brazil
View all 24 locations
View Trial Details
Active, not recruiting

A Study Comparing Treatment Preference Between Oral Decitabine/Cedazuridine and Azacitidine in Myelodysplastic Syndrome, Low-Blast Acute Myeloid Leukemia, or Chronic Myelomonocytic Leukemia

NCT05883956

Conditions
Behavior, Bone Marrow Diseases, Chronic Disease, +17 more
Locations
  • Calvary Mater Newcastle Newcastle, New South Wales, Australia
  • Pindara Private Hospital Benowa, Queensland, Australia
  • Townsville Hospital Townsville, Queensland, Australia
  • Adelaide Oncology and Haematology North Adelaide, South Australia, Australia
View Trial Details
Completed

Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)

NCT03268954

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +13 more
Locations
  • Southern Cancer Center - USOR Daphne, Alabama, United States
  • Southern Cancer Center - USOR Mobile, Alabama, United States
  • Southern Cancer Center - USOR Mobile, Alabama, United States
  • Southern Cancer Center- USOR Mobile, Alabama, United States
View all 242 locations
View Trial Details
Completed

A Study of Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems

NCT03814005

Conditions
Bone Marrow Diseases, Chronic Disease, Digestive System Diseases, +22 more
Locations
  • Icahn School of Medicine at Mount Sinai New York, United States
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
  • ICO lHospitalet Hospital Duran i Reynals LHospitalet de Llobregat, Barcelona, Spain
  • Hospital Universitario Vall d'Hebron - PPDS Barcelona, Spain
View Trial Details
Completed

Guadecitabine (SGI-110) vs Treatment Choice in Adults With MDS or CMML Previously Treated With HMAs

NCT02907359

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations
  • City of Hope Duarte, California, United States
  • Desert Hematology Oncology Medical Group, Inc. Rancho Mirage, California, United States
  • Cancer Specialists of North Florida Fleming Island, Florida, United States
  • Mount Sinai Medical Center Miami Beach, Florida, United States
View all 112 locations
View Trial Details
Completed

Tipifarnib in Subjects With Chronic Myelomonocytic Leukemia, Other MDS/MPN, and Acute Myeloid Leukemia

NCT02807272

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +10 more
Locations
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • Mayo Clinic Florida Jacksonville, Florida, United States
  • H. Lee Moffitt Cancer Center & Research Institute, Inc. Tampa, Florida, United States
  • Johns Hopkins University Baltimore, Maryland, United States
View Trial Details

Related conditions